FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113011402> ?p ?o ?g. }

• W2113011402 endingPage "222" @default.
• W2113011402 startingPage "217" @default.
• W2113011402 abstract "Lung cancer is one of the most lethal cancers in China because of high incidence and high mortality. Cyclooxygenase-2 (COX-2) and vessel endothelial growth factor C (VEGF-C) were found to play an important role in lymphangiogenesis of malignant tumors. In this study, we investigated whether lymphatic microvessel density (LMVD) is related to the prognosis in non-small cell lung cancer (NSCLC) patients, and the expressions of COX-2 and VEGF-C so as to determine the possible role of COX-2 and VEGF-C in NSCLC lymphangiogenesis. Sixty-five formalin-fixed paraffin embedded tissue samples of NSCLC were evaluated for COX-2 and VEGF-C by immunohistochemical staining. To assess tumor lymphangiogenesis, LMVD was determined by immunohistochemical staining of VEGFR-3 polyclonal antibody. The relationship among COX-2 and VEGF-C expression, LMVD, and clinicopathologic parameters was analyzed. Among the 65 samples, high LMVD was significantly associated with lymph node metastasis and poor survival. Multivariate survival analysis showed that LMVD value and lymph node metastasis were independent prognostic factors. The expression level of COX-2 and VEGF-C was significantly higher than those of the adjacent tissues. COX-2 and VEGF-C expressions in NSCLC significantly correlated with lymph node metastasis, but not with patient gender, age, tumor size, or tumor, nodes, metastasis classification stage. The mean LMVD value of COX-2- or VEGF-C-positive tumors was higher than that of COX-2- or VEGF-C-negative tumors. A significant correlation was found between the expressions of COX-2 and VEGF-C. This study suggests that LMVD may be one of the important prognostic factors for NSCLC patients. VEGF-C might play an important role in the COX-2 lymphangiogenic pathway. COX-2 and VEGF-C may play an important role in tumor progression by stimulating lymphangiogenesis. The inhibition of lymphangiogenesis, COX-2, or VEGF-C activity may have an important therapeutic benefit in the control of NSCLC." @default.
• W2113011402 created "2016-06-24" @default.
• W2113011402 creator A5008691388 @default.
• W2113011402 creator A5017742554 @default.
• W2113011402 creator A5024034623 @default.
• W2113011402 creator A5048260193 @default.
• W2113011402 creator A5049459411 @default.
• W2113011402 creator A5078402930 @default.
• W2113011402 date "2009-03-01" @default.
• W2113011402 modified "2023-10-03" @default.
• W2113011402 title "Prognostic significance of VEGF-C expression in correlation with COX-2, lymphatic microvessel density, and clinicopathologic characteristics in human non-small cell lung cancer" @default.
• W2113011402 cites W1974566521 @default.
• W2113011402 cites W1979839784 @default.
• W2113011402 cites W1992101966 @default.
• W2113011402 cites W2014485008 @default.
• W2113011402 cites W2033791124 @default.
• W2113011402 cites W2048678026 @default.
• W2113011402 cites W2058034201 @default.
• W2113011402 cites W2058118671 @default.
• W2113011402 cites W2063760352 @default.
• W2113011402 cites W2074639980 @default.
• W2113011402 cites W2076813980 @default.
• W2113011402 cites W2078422697 @default.
• W2113011402 cites W2085568473 @default.
• W2113011402 cites W2093342110 @default.
• W2113011402 cites W2093742534 @default.
• W2113011402 cites W2149233326 @default.
• W2113011402 cites W2149304811 @default.
• W2113011402 cites W2155144778 @default.
• W2113011402 cites W2160738204 @default.
• W2113011402 cites W2170339479 @default.
• W2113011402 cites W2170646126 @default.
• W2113011402 doi "https://doi.org/10.1093/abbs/gmp004" @default.
• W2113011402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19280060" @default.
• W2113011402 hasPublicationYear "2009" @default.
• W2113011402 type Work @default.
• W2113011402 sameAs 2113011402 @default.
• W2113011402 citedByCount "28" @default.
• W2113011402 countsByYear W21130114022012 @default.
• W2113011402 countsByYear W21130114022013 @default.
• W2113011402 countsByYear W21130114022014 @default.
• W2113011402 countsByYear W21130114022015 @default.
• W2113011402 countsByYear W21130114022016 @default.
• W2113011402 countsByYear W21130114022017 @default.
• W2113011402 countsByYear W21130114022021 @default.
• W2113011402 countsByYear W21130114022022 @default.
• W2113011402 countsByYear W21130114022023 @default.
• W2113011402 crossrefType "journal-article" @default.
• W2113011402 hasAuthorship W2113011402A5008691388 @default.
• W2113011402 hasAuthorship W2113011402A5017742554 @default.
• W2113011402 hasAuthorship W2113011402A5024034623 @default.
• W2113011402 hasAuthorship W2113011402A5048260193 @default.
• W2113011402 hasAuthorship W2113011402A5049459411 @default.
• W2113011402 hasAuthorship W2113011402A5078402930 @default.
• W2113011402 hasBestOaLocation W21130114021 @default.
• W2113011402 hasConcept C121608353 @default.
• W2113011402 hasConcept C126322002 @default.
• W2113011402 hasConcept C142724271 @default.
• W2113011402 hasConcept C143998085 @default.
• W2113011402 hasConcept C181152851 @default.
• W2113011402 hasConcept C204232928 @default.
• W2113011402 hasConcept C2776256026 @default.
• W2113011402 hasConcept C2776636583 @default.
• W2113011402 hasConcept C2779013556 @default.
• W2113011402 hasConcept C2780849966 @default.
• W2113011402 hasConcept C2780965494 @default.
• W2113011402 hasConcept C71924100 @default.
• W2113011402 hasConceptScore W2113011402C121608353 @default.
• W2113011402 hasConceptScore W2113011402C126322002 @default.
• W2113011402 hasConceptScore W2113011402C142724271 @default.
• W2113011402 hasConceptScore W2113011402C143998085 @default.
• W2113011402 hasConceptScore W2113011402C181152851 @default.
• W2113011402 hasConceptScore W2113011402C204232928 @default.
• W2113011402 hasConceptScore W2113011402C2776256026 @default.
• W2113011402 hasConceptScore W2113011402C2776636583 @default.
• W2113011402 hasConceptScore W2113011402C2779013556 @default.
• W2113011402 hasConceptScore W2113011402C2780849966 @default.
• W2113011402 hasConceptScore W2113011402C2780965494 @default.
• W2113011402 hasConceptScore W2113011402C71924100 @default.
• W2113011402 hasIssue "3" @default.
• W2113011402 hasLocation W21130114021 @default.
• W2113011402 hasLocation W21130114022 @default.
• W2113011402 hasOpenAccess W2113011402 @default.
• W2113011402 hasPrimaryLocation W21130114021 @default.
• W2113011402 hasRelatedWork W1477100607 @default.
• W2113011402 hasRelatedWork W1995871134 @default.
• W2113011402 hasRelatedWork W2020958716 @default.
• W2113011402 hasRelatedWork W2060933527 @default.
• W2113011402 hasRelatedWork W2108828143 @default.
• W2113011402 hasRelatedWork W2111533798 @default.
• W2113011402 hasRelatedWork W2348334654 @default.
• W2113011402 hasRelatedWork W2361199509 @default.
• W2113011402 hasRelatedWork W2385468713 @default.
• W2113011402 hasRelatedWork W4327896703 @default.
• W2113011402 hasVolume "41" @default.
• W2113011402 isParatext "false" @default.
• W2113011402 isRetracted "false" @default.
• W2113011402 magId "2113011402" @default.

• next